rs114036675

This is a protein-altering variant in the BCL3 gene.

GWAS Catalog Trait Associations (5)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

apolipoprotein B measurement

Sinnott-Armstrong N et al. Genetics of 35 blood and urine biomarkers in the UK Biobank. Nature Genetics 53(2):185-194 (2021)
Allele A
OR 0.16
p 5.0e-13
N 354,097
Major Consortium StudyLarge GWAS
multi-ancestry

family history of Alzheimer’s disease

Jiang L et al. A generalized linear mixed model association tool for biobank-scale data. Nature Genetics 53(11):1616-1621 (2021)
Allele A
OR 0.54
p 9.0e-12
N 417,805
Large GWAS
European

Alzheimer disease, family history of Alzheimer’s disease

Allele A
OR 6.29
p 3.0e-10
N 455,258
Meta-analysisLarge GWAS
European

low density lipoprotein cholesterol measurement

Sinnott-Armstrong N et al. Genetics of 35 blood and urine biomarkers in the UK Biobank. Nature Genetics 53(2):185-194 (2021)
Allele A
OR 0.14
p 3.0e-10
N 355,197
Major Consortium StudyLarge GWAS
multi-ancestry

total cholesterol measurement

Sinnott-Armstrong N et al. Genetics of 35 blood and urine biomarkers in the UK Biobank. Nature Genetics 53(2):185-194 (2021)
Allele A
OR 0.13
p 5.0e-9
N 355,858
Major Consortium StudyLarge GWAS
multi-ancestry

About BCL3

This gene is a proto-oncogene candidate. It is identified by its translocation into the immunoglobulin alpha-locus in some cases of B-cell leukemia. The protein encoded by this gene contains seven ankyrin repeats, which are most closely related to those found in I kappa B proteins. This protein functions as a transcriptional co-activator that activates through its association with NF-kappa B homodimers. The expression of this gene can be induced by NF-kappa B, which forms a part of the autoregulatory loop that controls the nuclear residence of p50 NF-kappa B. [provided by RefSeq, Jul 2008]

View all BCL3 variants →

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…